Article Text

Download PDFPDF
Sterile abscesses following administration of long-acting injectable rilpivirine for HIV
  1. Nathan L'Etoile1,2 and
  2. Elizabeth Lowenthal3,2
  1. 1Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
  2. 2General Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
  3. 3Center for AIDS Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
  1. Correspondence to Dr Nathan L'Etoile; letoilen{at}chop.edu

Abstract

Long-acting injectable antiretroviral therapy for HIV has improved treatment satisfaction with mild injection site reactions reported. We describe a case of a young adult with sterile abscesses at the sites of two consecutive injections. This case describes a significant side effect noted during post-market roll-out.

  • Drugs: infectious diseases
  • HIV / AIDS
  • Medical management
  • Safety
  • Unwanted effects / adverse reactions

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors The following authors were responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms, and critical revision for important intellectual content: NL’E and EL. The following authors gave final approval of the manuscript: NL’E and EL. NL’E is the guarantor.

  • Funding This study was funded by University of Pennsylvania Center for AIDS Research (P30 AI 045008),NIH Grants (T32AI055435).

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.